| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.15B | -25.8% |
| Cost of Revenue | $4.72B | -26.9% |
| Gross Profit | $433.0M | -11.1% |
| R&D Expense | $141.0M | -15.6% |
| SG&A Expense | $182.0M | -11.7% |
| Operating Income | -$320.0M | +17.1% |
| Pre-tax Income | -$391.0M | -42.7% |
| Income Tax | $1.0M | +0.0% |
| Net Income | -$392.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $671.0M | -32.8% |
| Short-term Investments | $8.0M | -88.4% |
| Current Assets | $3.00B | -13.0% |
| Total Assets | $3.13B | -12.4% |
| Current Liabilities | $529.0M | +655.7% |
| Total Liabilities | $2.41B | -7.2% |
| Stockholders' Equity | $713.0M | -26.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$595.0M | -125.4% |
| Capital Expenditures | $25.0M | -32.4% |
| Investing Cash Flow | $28.0M | -36.4% |
| Financing Cash Flow | -$210.0M | +92.0% |
| Free Cash Flow | -$620.0M | -126.9% |
| -42.5% |
| EPS (Basic) | -$0.56 | -33.3% |
| EPS (Diluted) | -$0.56 | -33.3% |